359 related articles for article (PubMed ID: 8634430)
1. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB
Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430
[TBL] [Abstract][Full Text] [Related]
2. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons.
Andrews RG; Winkler A; Myerson D; Briddell RA; Knitter GH; McNiece IK; Hunt P
Stem Cells; 1996 Nov; 14(6):661-77. PubMed ID: 8948024
[TBL] [Abstract][Full Text] [Related]
4. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
[TBL] [Abstract][Full Text] [Related]
5. Effects of Mpl ligands on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Kelly AB
Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
[TBL] [Abstract][Full Text] [Related]
6. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization.
Arnold JT; Daw NC; Stenberg PE; Jayawardene D; Srivastava DK; Jackson CW
Blood; 1997 Feb; 89(3):823-33. PubMed ID: 9028313
[TBL] [Abstract][Full Text] [Related]
7. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.
Harker LA; Roskos LK; Marzec UM; Carter RA; Cherry JK; Sundell B; Cheung EN; Terry D; Sheridan W
Blood; 2000 Apr; 95(8):2514-22. PubMed ID: 10753829
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.
Farese AM; Hunt P; Boone T; MacVittie TJ
Blood; 1995 Jul; 86(1):54-9. PubMed ID: 7795256
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic cytokine stimulation of thrombocytopoiesis.
Harker LA
Transfus Sci; 1998 Jun; 19(2):149-62. PubMed ID: 10187040
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
Neumann TA; Foote M
Cytokines Cell Mol Ther; 2000 Mar; 6(1):47-56. PubMed ID: 10976539
[TBL] [Abstract][Full Text] [Related]
11. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice.
Ulich TR; del Castillo J; Yin S; Swift S; Padilla D; Senaldi G; Bennett L; Shutter J; Bogenberger J; Sun D
Blood; 1995 Aug; 86(3):971-6. PubMed ID: 7620187
[TBL] [Abstract][Full Text] [Related]
12. Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia.
Tomer A
Blood; 2002 Mar; 99(5):1602-9. PubMed ID: 11861274
[TBL] [Abstract][Full Text] [Related]
13. Platelets in thrombotic disorders: quantitative and qualitative platelet disorders predisposing to arterial thrombosis.
Harker LA
Semin Hematol; 1998 Jul; 35(3):241-52. PubMed ID: 9685170
[TBL] [Abstract][Full Text] [Related]
14. The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice.
Ulich TR; del Castillo J; Senaldi G; Cheung E; Roskos L; Young J; Molineux G; Guo J; Schoemperlen J; Munyakazi L; Murphy-Filkins R; Tarpley JE; Toombs CF; Kaufman S; Yin S; Nelson AG; Nichol JL; Sheridan WP
Exp Hematol; 1999 Jan; 27(1):117-30. PubMed ID: 9923450
[TBL] [Abstract][Full Text] [Related]
15. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.
Choi ES; Hokom MM; Chen JL; Skrine J; Faust J; Nichol J; Hunt P
Br J Haematol; 1996 Nov; 95(2):227-33. PubMed ID: 8904874
[TBL] [Abstract][Full Text] [Related]
16. Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia.
McDonald TP; Cottrell MB; Steward SA; Clift RE; Swearingen CJ; Jackson CW
Exp Hematol; 1992 Jan; 20(1):51-6. PubMed ID: 1577094
[TBL] [Abstract][Full Text] [Related]
17. Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume.
Corash L; Chen HY; Levin J; Baker G; Lu H; Mok Y
Blood; 1987 Jul; 70(1):177-85. PubMed ID: 3593965
[TBL] [Abstract][Full Text] [Related]
18. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.
Rasko JE; O'Flaherty E; Begley CG
Stem Cells; 1997; 15(1):33-42. PubMed ID: 9007220
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin derived from human embryonic kidney cells stimulates an increase in DNA content of murine megakaryocytes in vivo.
McDonald TP; Jackson CW
Exp Hematol; 1990 Aug; 18(7):758-63. PubMed ID: 2199205
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand.
Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N
Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
